文献速递血栓与止血

烟酰胺通过促进Foxp3乙酰化增强免疫性血小板减少症中调节性T细胞分化

Nicotinamide enhances Treg differentiation by promoting Foxp3 acetylation in immune thrombocytopenia.
PubMed 文献 · Br J Haematol · 2024-10-15

研究发现免疫性血小板减少症(ITP)患者血浆和CD4+ T细胞中NAD+水平降低,补充NAD+前体烟酰胺(NAM)而非烟酰胺单核苷酸(NMN)可增加ITP小鼠模型中的Treg频率并改善血小板减少。机制上,NAM作为Sirt1抑制剂促进Foxp3乙酰化及稳定性,提示NAM有望成为恢复ITP免疫平衡的新治疗策略。

要点

  • ITP患者血浆和CD4+ T细胞中NAD+水平降低
  • NAM而非NMN在ITP小鼠模型中增加Treg频率并改善血小板减少
  • NAM通过抑制Sirt1促进Foxp3乙酰化和稳定性

核心结论

  • NAM通过促进Foxp3乙酰化增强Treg分化,有望成为恢复ITP免疫平衡的新型治疗策略。

研究设计与样本

  • 研究检测了ITP患者血浆和CD4+ T细胞中NAD+水平,并在ITP小鼠模型中比较NAM与NMN对Treg频率和血小板减少的影响。

主要发现

  • ITP患者血浆和CD4+ T细胞中NAD+水平降低。
  • 在ITP小鼠模型中,补充NAM而非NMN可增加Treg频率并改善血小板减少。
  • NAM和NMN均能恢复ITP患者CD4+ T细胞的胞质NAD+水平,但仅NAM促进Treg分化。
  • ITP患者CD4+ T细胞中Sirt1高表达,可能 contribuir 于NAD+低水平。
  • NAM作为Sirt1抑制剂,促进ITP患者初始CD4+ T细胞来源的诱导性Treg中Foxp3乙酰化和稳定性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Imbalanced nicotinamide adenine dinucleotide (NAD+) homeostasis has been reported in multiple autoimmune diseases and supplementation with NAD+ precursors has consistently demonstrated positive therapeutic benefits for these conditions. Immune thrombocytopenia (ITP) is an acquired autoimmune disease, in which the decreased number and impaired function of regulatory T cells (Tregs) contribute to the main pathogenesis. Here we found NAD+ level was decreased in the plasma and CD4+ T cells of ITP patients. Supplementation with NAD+ precursor nicotinamide (NAM), but not nicotinamide mononucleotide (NMN), increased Treg frequency and ameliorated thrombocytopenia in an ITP murine model. Moreover, whilst both NAM and NMN restored cytosolic NAD+ level in the CD4+ T cells from ITP patients, only NAM promoted Treg differentiation. Mechanistically, Sirtuin1 (Sirt1), a major consumer of NAD+, was highly expressed in the CD4+ T cells of ITP patients, potentially contributing to the low level of NAD+. NAM, which could act as Sirt1 inhibitor, promoted Foxp3 acetylation and stability in induced Tregs derived from naïve CD4+ T cells of ITP patients. These findings suggest that NAM holds promise as a novel therapeutic strategy for restoring immune balance in ITP.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Li J, Zhang C, Hu Y, et al. Nicotinamide enhances Treg differentiation by promoting Foxp3 acetylation in immune thrombocytopenia. Br J Haematol. 2024. PMID: 39406393. doi:10.1111/bjh.19820

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。